STIM1 activates store-operated Ca 2+ entry (SOCE) by translocating to endoplasmic reticulum-plasma 11 membrane junctions. Chang et al. revealed that STIM1 localization and SOCE are regulated by a 12 diffusion trap mechanism mediated by STIM1 binding to EB1 at growing microtubule ends. 13
Introduction 27
Ca 2+ is a universal second messenger that governs many important cellular functions, such as secretion, 28 cell migration, differentiation, and apoptosis (Berridge et al., 2000; Dupont et al., 2011; Lewis, 2011) . 29
Elevation of cytosolic Ca 2+ via inositol 1,4,5-triphosphate (IP3)-induced Ca 2+ release from the 30 endoplasmic reticulum (ER) store following cell surface receptor activation is the key to Ca 2+ signaling. 31
Animal cells have evolved a feedback mechanism, namely store-operated Ca 2+ entry (SOCE) that links 32 ER Ca 2+ store depletion to a Ca 2+ influx across the plasma membrane (PM) from the extracellular space to 33 support sustained Ca 2+ signaling and ER Ca 2+ store refill (Feske and Prakriya, 2013; Prakriya and Lewis, 34 2015). The importance of SOCE is demonstrated by the patients with mutations in SOCE components 35 manifesting the symptoms of immunodeficiency, autoimmunity, and skeletal myopathy (Feske, 2011) . 36 SOCE is mediated by the ER Ca 2+ sensor STIM1 and the PM Ca 2+ channel Orail. The activation 37 of SOCE is a dynamic process involving changes in STIM1 subcellular localization. STIM1 is an ER 38 transmembrane (TM) protein with an N-terminal Ca 2+ -sensing EF hand-SAM (EF-SAM) domain in the 39 ER lumen ( Figure 1A) . The cytosolic portion of STIM1 contains coiled-coil domains (CC1 to CC3), a 40 serine/proline (S/P) region, and a C-terminal region (CT, amino acid 633-685, Figure 1A ) with a 41 polybasic motif (PB). In the resting state, STIM1 binds to Ca 2+ in the ER lumen and localizes diffusely 42 throughout the ER (Liou et al., 2005) . Following ER Ca 2+ store depletion, Ca 2+ -free STIM1 rapidly 43 oligomerizes leading to a conformational extension of the PB and the Orai1 activation domain, namely 44 CAD, SOAR, or CC9 that roughly corresponds to the CC2-CC3 domains ( appositions allowing STIM1 at the ER to activate Orai1 at the PM resulting in SOCE. STIM1 targeting to 49 ER-PM junctions is a rate-limiting step in the activation of SOCE. Although STIM1 oligomerization 50 occurs within 5 s following ER Ca 2+ store depletion, it takes more than 40 s for STIM1 to translocate to 51 5 ER-PM junctions (Liou et al., 2007) . The mechanism underlying the time discrepancy between STIM1 52 oligomerization and translocation is not clear. 53
In addition to PIP2 and Orail binding, STIM1 directly interacts with the microtubule (MT)-plus-54 end binding proteins EB1 and EB3 to a lesser extent (Grigoriev et al., 2008) . These interactions are 55 mediated by an EB1 binding motif that resides in the CT. STIM1 interaction with EB1 at MT plus-ends 56 can be visualized using live-cell imaging as overexpressed STIM1 adopts MT-like organization and 57 To dissect the contribution of EB1 binding to STIM1 localization and function, we generated 64 iMAPPER-633, a mini-STIM1 construct that contains the ER targeting motifs and the CT (amino acid 65 633-685), and lacks the EF-SAM, coiled-coil domains and the S/P region to mediate Ca 2+ sensing, Orai1 66 binding and phosphorylation, respectively. iMAPPER-633 binds to EB1 at MT plus-ends and translocates 67 to ER-PM junctions following chemically-induced oligomerization, indicating that it contains the 68 necessary components to recapitulate STIM1 localization in the resting state and during ER Ca 2+ store 69 depletion. Experiments using iMAPPER-633 also revealed that EB1 binding is dominant over PIP2 70 binding within the CT and that oligomerization strongly potentiates PIP2 binding, resulting in 71 translocation. We further showed that EB1 binding restricts STIM1 diffusion in the ER and limits STIM1 72 access to ER-PM junctions in the resting state and during ER Ca 2+ store depletion. Disruption of EB1 73 binding facilitates Orai1 recruitment and SOCE activation, resulting in ER Ca 2+ overload. Together, our 74 findings indicate that EB1 binding provides a diffusion trap mechanism regulating STIM1 localization 75 and SOCE, and suggest that STIM1-mediated Ca 2+ signaling may be locally regulated by binding to EB1 76 on growing MT ends. 77 6 Results 78
iMAPPER-633: a mini-STIM1 construct that recapitulates dynamic STIM1 subcellular localization 79
The localization of STIM1 is regulated by multiple factors including ER Ca 2+ levels, oligomerization, 80 phosphorylation, as well as binding to Orai1, PIP2, and EB1. The role of EB1 binding in regulating 81 STIM1-mediated Ca 2+ signaling at ER-PM junctions is not well understood. To dissect the contribution of 82 EB1 binding in STIM1 translocation to ER-PM junctions, we employed a reconstitution approach and 83 engineered a mini-STIM1 construct that contains the signal peptide (SP) and TM of STIM1 for ER 84 membrane localization, as well as the CT of STIM1 enabling its binding to EB1 and PIP2 ( Figure 1A) . A 85 tandem FKBP (FK506 binding protein) motif (2X FKBP) was inserted into the ER luminal region 86 following a fluorescence protein (FP) to enable oligomerization upon treatment of a small molecule 87 AP20187, and optical imaging, respectively. ( Figure 1B ). We further added in the cytosolic linker region 88 of the synthetic ER-PM junctional marker MAPPER (Chang et al., 2013) , which has been shown to 89 provide the proper length spanning the gap at ER-PM junctions. We named this mini-STIM1 construct 90 "iMAPPER-633" (inducible MAPPER-633) because its design resembles MAPPER and features 91 inducible translocation to ER-PM junctions via the CT of STIM1 starting at residue 633. An intermediate 92 construct containing the SP, an FP, the 2X FKBP, and the TM displayed ER localization when expressed 93 in HeLa cells, indicating successful ER targeting ( Figure S1A ). Unlike the CT in full-length STIM1 94 which is partially buried in the resting state (Zhou et al., 2013) , the CT in iMAPPER-633 is expected to 95 be fully exposed, facilitating assessment of the contribution of EB1-binding and PIP2-binding motifs to 96 STIM1 localization ( Figure 1B) . 97
When iMAPPER-633-transfected HeLa cells were examined under confocal microscopy, 98 iMAPPER-633 displayed comet-like structures moving toward the cell periphery, similar to resting 99 STIM1 that binds to EB1 at MT plus-ends (upper panels in Figure 1C and Movie S1). These iMAPPER-100 633 comets colocalized with an ER luminal marker and with STIM1 ( Figures 1C and S1B ), suggesting 101 that iMAPPER-633 is an ER protein concentrated at the contacts between MT plus-ends and the ER.
7
Consistent with the expectation that the CT of iMAPPER-633 is fully exposed and more accessible to 103 EB1 binding than that of STIM1, iMAPPER-633 appeared to be more concentrated in MT-like structures 104 than in the ER compared to STIM1 ( Figure S1B ). The extensive trapping of iMAPPER-633 at MT-like 105 structures was accompanied by a few highly concentrated iMAPPER-633 clusters with apparent 106 movement toward the nucleus, possibly formed due to loss of EB1 binding during MT catastrophe 107 (Figure S1B yellow arrowheads). When AP20187 was applied to induce oligomerization, iMAPPER-633 108 rapidly translocated into puncta while the bulk ER structure was unaffected (lower panels in Figure 1C ). 109
Colocalization of iMAPPER-633 with MAPPER, monitored by total internal reflection fluorescence 110 (TIRF) microscopy, indicates that iMAPPER-633 puncta formation corresponds to its translocation to 111 ER-PM junctions ( Figure 1D ). These results further suggest that iMAPPER-633 contains targeting motifs 112 sufficient for recapitulating the subcellular localization of STIM1 in the resting state as well as in the 113 oligomized state induced by ER Ca 2+ store depletion. These results also revealed that the exposed CT of 114 STIM1 preferentially binds to EB1 at MT plus-ends rather than PIP2 at the PM, and that oligomerization 115 strongly potentiates PIP2 binding, resulting in translocation. 116
Inhibition of EB1 binding triggers iMAPPER-633 translocation to ER-PM junctions 117
Next, we applied nocadazole (NocZ), an inhibitor of MT polymerization, to disrupt EB1-MT association. 118
We found that iMAPPER-633 translocated to ER-PM junctions following NocZ treatment as EB1 comets 119 disappeared ( Figure 2A ). Consistently, we observed that iMAPPER-633 readily localized at ER-PM 120 junctions in cells with EB1 knockdown by small interfering RNA against EB1 (siEB1) ( Figures 2B and  121 2C). We further generated the iMAPPER-633-TRNN mutant incapable of EB1 binding and found that 122 iMAPPER-633-TRNN pre-localized to ER-PM junctions (upper panels in Figure 2D ). Notably, the 123 intensity of iMAPPER-633-TRNN puncta remained similar following AP20187 treatment, suggesting 124 that the majority of iMAPPER-633-TRNN was trapped at ER-PM junctions as a result of its inability of 125 EB1 binding (lower panels in Figure 2D ). These data indicate that the PB in the exposed CT is sufficient 126 for trapping iMAPPER-633 at ER-PM junctions and that EB1 binding diverts iMAPPER-633 to be 127 trapped at MT plus-ends, preventing its localization at ER-PM junctions. 128
Unlike iMAPPER-633-TRNN, the STIM1-TRNN mutant showed a uniform distribution 129 throughout the ER with minimal pre-localization at ER-PM junctions and no comet-like structures ( Figure  130 2E). ER Ca 2+ store depletion by thapsigargin (TG) was required to trigger STIM1-TRNN translocation to 131 ER-PM junctions to co-localize with iMAPPER-633-TRNN. These results are consistent with a previous 132 finding that the CT in full-length STIM1 is partially buried and is incapable of binding to PIP2 in the PM 133 until STIM1 activation following ER Ca 2+ depletion (Zhou et al., 2013) . We further generated a STIM1-134
2K construct by adding an extra PB to the very C-terminus of STIM1 to enhance its PM binding affinity. 135
This STIM1-2K construct with two PB in tandem in the CT pre-localized to ER-PM junctions without ER 136 Ca 2+ store depletion ( Figure 2F ). Similar pre-localization has been observed with the STIM1-D76A 137 mutant that contains a point mutation disrupting its ability to bind ER Ca 2+ and exhibits an active 138 conformation (Liou et al., 2005) . Unlike STIM1-D76A, expression of STIM1-2K did not increase basal 139
Ca 2+ levels ( Figure 2G ), suggesting that STIM1-2K is not in an active conformation. These results 140 indicate that increased PM binding affinity can cause STIM1 trapping at ER-PM junctions without 141 activating SOCE. 142
EB1 binding constitutes a diffusion trap limiting STIM1 localization at ER-PM junctions 143
By binding to EB1 at MT plus-ends, STIM1 is transiently trapped at ER regions in contact with growing 144 MT end. To examine the effect of EB1 binding on STIM1 diffusion, we performed fluorescence recovery 145 after photobleaching (FRAP) experiments using cells transfected with STIM1 or STIM1-TRNN. We 146 found that STIM1-TRNN fluorescence recovered faster than that of STIM1 in the bleached regions with a 147 significant difference in the time required to reach the half recovery (t1/2) ( Figures 3A and 3B ). These 148 results demonstrate that STIM1-EB1 interaction restricts STIM1 diffusion in the ER membrane. Trapping 149 by EB1 at MT plus-ends likely limits the amount of STIM1 molecules accessing other ER regions 150
including ER-PM junctions. To test this hypothesis, we monitored ER-PM junctions in cells co-151 transfected with a mCherry-tagged ER luminal marker and YFP-tagged STIM1 using TIRF microscopy. 152
Following NocZ treatment, an increase in the intensity ratio of STIM1 over the ER marker at ER-PM 153 junctions was observed, whereas the intensity ratio of STIM1-TRNN over the ER marker at ER-PM 154 junctions remained the same ( Figures 3C, 3D and 3E). These findings indicate that NocZ treatment 155 released the sub-population of STIM1 trapped by EB1 at MT plus-ends, resulting in an increase of STIM1 156 molecules diffusing through ER-PM junctions in resting cells. 157
Activated STIM1 retains EB1 binding ability in ER Ca 2+ -depleted cells 158
A previous report suggested that STIM1 oligomerization following ER Ca 2+ store depletion does not 159 preclude its association with endogenous EB proteins (Grigoriev et al., 2008) . In support of this idea, we 160 observed partial co-localization of STIM1 and EB1 after TG treatment ( Figure 4A ). Consistently, 161 immuneprecipitation (IP) experiments showed that a portion of mCherry-STIM1 remained bound to EB1-162 GFP following TG treatment while mCherry-STIM1-TRNN showed negligible interaction with EB1-GFP 163 ( Figures 4B and S2A ). We further applied 100 µM ML-9, which has been shown to rapidly trigger 164 STIM1 dissociation from ER-PM junctions and reversion of puncta formation (Smyth et al., 2008), to 165 cells co-transfected with STIM1 and EB1 during ER Ca 2+ store depletion. Following ML-9 treatment, 166 TG-induced STIM1 puncta rapidly disappeared and STIM1-trapping by EB1 became apparent without 167 refilling the ER Ca 2+ store ( Figure 4C ). The disappearance of STIM1 puncta induced by ML-9 treatment 168 was not due to the disruption of ER-PM junctions as monitored by an ER luminal marker using TIRF 169 microscopy ( Figure 4D ). It is possible that ML-9 abolishes STIM1 trapping by PM PIP2 since STIM1 170 trapping at ER-PM junctions by Orai1 was not affected by ML-9 treatment ( Figure S2B ). Furthermore, 171
we found that STIM1-D76A, a constitutively active mutant that pre-localizes at ER-PM junctions without 172 ER Ca 2+ store depletion, was immediately trapped by EB1 following ML-9 treatment ( Figure 4E ; Movie 173 S2), whereas STIM1-D76A-TRNN displayed ER localization after ML-9-induced dissociation from ER-174 PM junctions ( Figure 4F ). Together, these results demonstrate that STIM1 can bind to EB1 at MT plus-10 ends regardless of its activation state and the level of ER Ca 2+ store. These findings indicate that EB1 at 176 MT plus-ends can still capture and trap STIM1 during ER Ca 2+ depletion. 177
EB1 binding impedes STIM1 translocation to ER-PM junctions and Orai1 recruitment during ER 178

Ca 2+ depletion 179
We then reasoned that the diffusion trap mechanism mediated by EB1 binding may impede STIM1 180 translocation to ER-PM junctions following ER Ca 2+ store depletion. Consistent with this notion, we 181 observed nearly complete translocation of YFP-STIM1-TRNN 30 s after 1 µM ionomycin treatment 182 while YFP-STIM1 only began to accumulate at ER-PM junctions ( Figure 5A ). The t1/2 of STIM1 183 translocation to ER-PM junctions was 56.2 s ( Figure 5B ), which is comparable to a previous report (Liou 184 et al., 2007) . By contrast, STIM1-TRNN showed a significantly faster translocation than STIM1 with a 185 t1/2 of 22.5 s. A higher amplitude of STIM1-TRNN translocation to ER-PM junctions than that of STIM1 186 was observed, indicating enhanced accumulation of STIM1-TRNN compared to STIM1 at ER-PM 187 junctions ( Figure 5B ). The kinetic differences in translocation to ER-PM junctions between STIM1 and 188 STIM1-TRNN were also detected in cells treated with TG ( Figures S3A and S3B ). Consistently, a 189 significant increase in the rate of STIM1 translocation following ionomycin treatment was detected in 190 siEB1-treated cells compared with those treated with siControl ( Figures S3C and S3D ). Notably, 191 disruption of STIM1-EB1 interaction consistently led to an accelerated STIM1 translocation by 23-34 s 192 regardless of the rate of ER Ca 2+ store depletion. These results indicate that trapping by EB1 at MT plus-193 ends delays diffusion of STIM1 oligomers to ER-PM junctions during ER Ca 2+ store depletion. overexpressing cells compared with STIM1-overexpressing one ( Figure 5D ). These data indicate that 202 STIM1-trapping by EB1 at MT plus-ends delays the binding and recruitment of Orai1 by STIM1 at ER-203 PM junctions during ER Ca 2+ store depletion. 204
Disruption of EB1 binding facilitated SOCE and resulted in ER Ca 2+ store overload 205 STIM1 interaction with Orai1 at ER-PM junctions initiates SOCE. Thus, regulation of STIM1 206 localization by EB1 binding in the resting state and during ER Ca 2+ store depletion likely shapes the 207 dynamics and extent of SOCE. Consistent with this notion, the sustained phase of cytosolic Ca 2+ levels 208 following ER Ca 2+ depletion induced by histamine and TG treatment in siEB1-treated cells was higher 209 than that in siControl-transfected cells, suggesting an enhanced SOCE ( Figure 6A ). Next, we selectively 210 monitored Ca 2+ entry from the extracellular space following ER Ca 2+ store depletion as a specific readout 211 for SOCE and found that knockdown of EB1 resulted in a significant increase in the amplitude of SOCE 212 ( Figure 6B ). Consistently, STIM1-TRNN overexpression also led to a significant enhancement of SOCE 213 than that mediated by STIM1 overexpression ( Figure 6C ). The effect of EB1-mediated STIM1 diffusion 214 trap on Ca 2+ signaling was further exemplified in experiments using the constitutively active STIM1-215 D76A and STIM1-D76A-TRNN constructs. Overexpression of STIM1-D76A led to a marked increase in 216 basal cytosolic Ca 2+ levels compared to control (STIM1-D76A vs. TM, Figure 6D ). This increase is due 217 to a constitutive SOCE because removal of extracellular Ca 2+ rapidly decreased the cytosolic Ca 2+ to the 218 control level and re-addition of extracellular Ca 2+ rapidly restored the elevated cytosolic Ca 2+ level in 219 STIM1-D76A overexpressing cells. Overexpression of STIM1-D76A-TRNN further potentiates the 220 elevated cytosolic Ca 2+ level at basal and following re-addition of extracellular Ca 2+ ( Figure 6D ). 221
Together, these results indicate that EB1 binding limits STIM1 localization at ER-PM junctions, 222 dampening the amplitudes of STIM1-mediated SOCE. 223
A main function of SOCE is to refill the ER Ca 2+ store following depletion. We further tested if 224 enhanced SOCE caused by the absence of STIM1-EB1 interaction results in ER Ca 2+ store overload. In 225 the resting cells, we observed a significantly elevated ER Ca 2+ store in siEB1-treated cells as monitored 226 by the release of ER Ca 2+ by ionomycin treatment in the absence of extracellular Ca 2+ ( Figure 6E ). We 227 further tracked the dynamic changes in ER Ca 2+ levels during store depletion and refill using an ER Ca 2+ 228 sensor D1ER (Palmer et al., 2004) and a reversible SERCA inhibitor named BHQ. We found that the 229 level of ER Ca 2+ was moderately elevated in STIM1-TRNN-transfected cells compared with that in 230 STIM1-transfected cells before and after depletion by BHQ ( Figure 6F , phases I and II). Following BHQ 231
washout and re-addition of extracellular Ca 2+ , a significant elevation in the ER Ca 2+ level was observed in 232 STIM1-TRNN-overexpressing cells compared with that in STIM1-overexpressing cells ( Figure 6F , phase 233 III and IV). Notably, the ER Ca 2+ level after refill was comparable to that before BHQ-induced depletion 234 in STIM1-overexpressing cells ( Figure 6G) ; however, the level of ER Ca 2+ after refill was significantly 235 higher than that before depletion in STIM1-TRNN-overexpressing cells. These results indicate that EB1 236
binding constitutes a mechanism that optimizes SOCE and prevents ER Ca 2+ store overload. 237
Discussion 238
Based on our findings, we propose a model in which EB1-mediated diffusion trapping of STIM1 239 optimizes SOCE at ER-PM junctions and prevents ER Ca 2+ overload (Figure 7) . In the resting state, EB1 240 binding traps STIM1 at growing MT ends, restricting the amount of freely diffusible STIM1 in the ER 241 membrane. Following ER Ca 2+ store depletion, EB1 binding continues to serve as a counterbalance 242 mechanism, limiting STIM1 localization at ER-PM junctions and activation of SOCE. In subcellular 243 regions without growing MT, freely diffusible STIM1 molecules in the ER can readily bind to PM PIP2 to 244 mediate SOCE at ER-PM junctions following ER Ca 2+ store depletion. Without the counterforce provided 245 by EB1 binding, STIM1 stays longer at ER-PM junctions, resulting in elevated SOCE and ER Ca 2+ store 246
overload. 247
This model can be further applied to understand physiological functions in cells with polarized 248 iMAPPER-633, a mini-STIM1 construct that contains the ER targeting motifs, an FP, a chemically-263 inducible oligomerization unit, cytosolic linkers, and the CT of STIM1, the subcellular localization of 264 STIM1 in the resting state and during ER Ca 2+ depletion was successfully recapitulated. This 265 reconstitution approach revealed that the EB1 trapping mechanism is dominant over PM targeting via the 266 PB even in the exposed CT. We further found that the PB in the exposed CT is sufficient for PM targeting 267 since disrupting STIM1-EB1 interaction led to a clear shift of iMAPPER-633 localization to ER-PM 268 junctions without oligomerization. Oligomerization likely creates a stronger polybasic motif for PIP2 269 binding, enabling a shift of iMAPPER-633 trapping at MT plus-ends to ER-PM junctions. Thus, it is 270 likely that STIM1 activation not only exposes the PB but also generates a stronger PB by oligomerization 271 that counterbalances the EB1-mediated trapping mechanism, leading to translocation to ER-PM junctions. 272
Consistent with this notion, STIM1-2K with an enhanced PB shifts the balance toward PM binding and 273 distributes to ER-PM junctions prior to STIM1 activation. 274
We demonstrated that EB1 binding significantly reduces STIM1 diffusion in the bulk of the ER. Moreover, we demonstrated that the trapping mechanism mediated by EB1 works continuously 286 during SOCE since activated STIM1 was recaptured by EB1 following the disruption of PM trapping by 287 ML-9, a potent inhibitor of myosin light chain kinase (MLCK). The effects of ML-9 on STIM1 appeared 288 to be independent of MLCK inhibition since knockdown of MLCK had no effect on SOCE (Smyth et al., 289 2008). Consistent with a previous observation that ML-9 was ineffective in inhibiting SOCE when both 290 STIM1 and Orai1 were overexpressed, we found STIM1-Orai1 clusters remained similar following ML-9 291 treatment ( Figure S2B ). Thus, it is possible that ML-9 affects STIM1 interaction with PIP2 at the PM. A previous study demonstrated that STIM1 phosphorylation at residue S575, S608, and S621 by 297
ERK1/2 is important for STIM1 dissociation from EB1 and translocation to ER-PM junctions during ER 298
Ca 2+ store depletion (Pozo-Guisado et al., 2013). Intriguingly, STIM1 phosphorylation was detected 2-5 299 min after TG treatment, arguing that STIM1 phosphorylation may occur after its translocation to ER-PM 300 junctions. Nonetheless, STIM1 phosphorylation may provide a mechanism to disengage EB1 trapping for 301 enhancing SOCE under certain conditions, such as cell migration (Casas-Rua et al., 2015) . 302
Phosphorylation of STIM1 may also be relevant during cell division since dissociation of phosphorylated 303 STIM1 from EB1 is required for exclusion of the ER from mitotic spindles (Smyth et al., 2012). 304 SOCE is one of the most important pathways for Ca 2+ signaling and homeostasis. Thus, the 305 precise spatial-temporal regulation of SOCE is crucial for supporting cellular functions and health. Here 306 we reveal an unexpected role of MT plus-ends in optimizing STIM1 translocation and SOCE via the EB1-307 mediated trapping mechanism and show that STIM1-EB1 interaction is important for preventing Ca 2+ 308 overload, which has been associated with many pathological conditions including stroke, 309 neurodegeneration and cancer (Dong et al., 2006; Orrenius et al., 2003; Trump and Berezesky, 1995) . Our 310 study on the crosstalk between MT plus-ends and STIM1-mediated SOCE may shed light on how cells 311 dynamically coordinate MT growth to regulate Ca 2+ signaling in physiological processes. 312
Materials and methods 313
Reagents 314
Thapsigargin (TG), Pluronic F-127, and Fura-2 AM were purchased from Invitrogen (Carlsbad, CA). All 315 chemicals for extracellular buffer (ECB, 125 mM NaCl, 5 mM KCl, 1.5 mM MgCl2, 20 mM HEPES, 10 316 mM glucose, and 1.5 mM CaCl2, pH 7.4), penicillin and streptomycin solution, ML-9, nocodazole 317 (NocZ), ionomycin, histamine, and EGTA were obtained from Sigma (St. Louis, MO). AP20187 was 318 purchased from Clontech (Mountain View, CA). BHQ was obtained from Calbiochem (Billerica, MA). 319
Anti-EB1 antibody (ab53358) and anti-beta actin antibody (ab8227) were obtained from Abcam 320 (Cambridge, MA). Human cDNA library and small interfering RNA (siRNA) used in this study were 321 generated as described previously (Liou et al., 2005) . Primers used for siRNA generation are listed in 322 Table S1 . mutants of STIM1 and iMAPPER-633 were generated using QuickChange site-direct mutagenesis kit 336 (Agilent Technologies, Santa Clara, CA). STIM1-2K was generated by site-directed mutagenesis to insert 337 a fragment encoding glycine, alanine, glycine and amino acids 671 to 685 before the stop codon of 338 STIM1. EB1-GFP and EB1-mCherry were cloned by inserting a PCR fragment containing EB1 into GFP-339 N1 and mCherry-N1 plasmids, respectively. All constructs listed here were verified by sequencing. All 340 oligonucleotides used in this study are listed in Table S1 . 341
Immunoprecipitation 342
HeLa cells were cultured on 6-well plates and transfected with EB1-GFP (300 ng/well) and mCherry-343 STIM1 subtypes (200 ng/well) for overnight. Cells were then washed with warm PBS before lysis with 20 344 mM Tris buffer, pH 7.5 containing 100 mM NaCl, 0.5% NP-40, and protease inhibitors on ice for 30 min. 345
The lysates were subjected to centrifugation at 16,000 X g for 15 min at 4°C and the clear lysates 346 were analyzed and normalized to a non-bleached area in the same cells. For the analyses of STIM1 364 subtypes and Orai1 translocation to ER-PM junctions, 20 to 30 puncta in each cell from TIRF images 365 were selected. The intensity traces of the selected puncta from the same cell were background subtracted, 366 normalized to time zero, and averaged. 367
Cytosolic and ER Ca 2+ Levels Measurement 368
For measuring cytosolic Ca 2+ levels, HeLa cells were loaded with 0.5 µM fura-2 AM in ECB containing 369 0.05% pluronic F-127 and 0.1% of BSA for 30 minutes at room temperature avoiding light. Loaded cells 370
were then washed with ECB containing 0.1% BSA, and incubated in ECB for another 15-30 minutes 371 before the experiments. Single-cell Ca 2+ images were taken with a Plan Fluor 4X objective (NA 0.15) and 372 an automated microscope custom-built on a Nikon Eclipse Ti microscope with a camera (HQ2; 373 Photometrics). The microscope was controlled by Micro-Manager software (Edelstein et al., 2010) . 374
Intracellular Ca 2+ levels were indicated by ratio of emission 510 nm excited at 340 nm over those at 380 375 nm. To measure ER Ca 2+ levels, HeLa cells were co-transfected with D1ER and mCherry-STIM1 or 376 mCherry-STIM1-TRNN. Single-cell Ca 2+ images were taken with a Plan Fluor 40X objective (NA 1.30) 377 and a confocal-TIRF microscope custom-built using a Nikon Eclipse Ti microscope with an HQ2 camera 378 and an EM camera (c9100-13; Hamamatsu). Dynamic changes in ER Ca 2+ levels were indicated by the 379 ratio of FRET (CFP excitation-YFP emission) signal to that of CFP. 380 
Statistical Analysis 381
